Therefore, it will be very useful to study the anti-inflammatory effect of chymase inhibitors in COPD models to dissect the underlying mechanisms and may provide an alternative therapeutic target for COPD treatment in the near future. Here, CMA1 is linked to chronic obstructive pulmonary disease.